These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 962233)

  • 1. Letter: Preventing isoniazid hepatotoxicity.
    Moulding R; Iseman M; Sbarbaro J
    Ann Intern Med; 1976 Sep; 85(3):398-9. PubMed ID: 962233
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nonmedicinal prevention of liver involvement caused by isoniazid and monoacetylhydrazine in rats].
    Koriakin VA; Nikolaev VP; Sokolova GB; Ziia AV; Abramovich AG; Protopopova MM
    Probl Tuberk; 1987; (12):49-52. PubMed ID: 3444826
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective effects of the bioactive natural product N-trans-Caffeoyldopamine on hepatotoxicity induced by isoniazid and rifampicin.
    Wu ZR; Bai ZT; Sun Y; Chen P; Yang ZG; Zhi DJ; Li Y; Wang X; Du JJ; Yang R; Cui P; Zhang Y; Li HY
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5424-6. PubMed ID: 26410075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats.
    Santhosh S; Sini TK; Anandan R; Mathew PT
    Eur J Pharmacol; 2007 Oct; 572(1):69-73. PubMed ID: 17612523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine inhibits the formation of the reactive, toxic metabolite of isoniazid in rats but not in man.
    Lauterburg BH; Todd EL; Smith CV; Mitchell JR
    Hepatology; 1985; 5(4):607-9. PubMed ID: 4018731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin.
    Raghu R; Karthikeyan S
    Environ Toxicol Pharmacol; 2016 Sep; 46():217-226. PubMed ID: 27497728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats.
    Saad EI; El-Gowilly SM; Sherhaa MO; Bistawroos AE
    Food Chem Toxicol; 2010 Jul; 48(7):1869-75. PubMed ID: 20417245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid-induced hepatotoxicity in rat hepatocytes of gel entrapment culture.
    Shen C; Zhang H; Zhang G; Meng Q
    Toxicol Lett; 2006 Nov; 167(1):66-74. PubMed ID: 17030102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Review of the current state of knowledge on prophylactic use of INH].
    Chwalibóg B
    Pneumonol Pol; 1980 Aug; 48(8):553-61. PubMed ID: 6999466
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatoprotection by carotenoids in isoniazid-rifampicin induced hepatic injury in rats.
    Rana SV; Pal R; Vaiphei K; Ola RP; Singh K
    Biochem Cell Biol; 2010 Oct; 88(5):819-34. PubMed ID: 20921993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the role of acetylhydrazine in isoniazid hepatotoxicity.
    Timbrell JA
    Arch Toxicol Suppl; 1979; (2):1-8. PubMed ID: 288324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: The isoniazid problem.
    Reichman LB
    Gastroenterology; 1976 Apr; 70(4):631-2. PubMed ID: 1254146
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage.
    Enriquez-Cortina C; Almonte-Becerril M; Clavijo-Cornejo D; Palestino-Domínguez M; Bello-Monroy O; Nuño N; López A; Bucio L; Souza V; Hernández-Pando R; Muñoz L; Gutiérrez-Ruiz MC; Gómez-Quiroz LE
    Toxicol Sci; 2013 Sep; 135(1):26-36. PubMed ID: 23764483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by
    Ruan LY; Fan JT; Hong W; Zhao H; Li MH; Jiang L; Fu YH; Xing YX; Chen C; Wang JS
    Toxicol Lett; 2018 Oct; 295():256-269. PubMed ID: 29936297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatotoxic effect of a combination of pyrazinamide with isoniazid and rifampicin].
    Slivka IuI; Klimniuk EV; Tabachuk OE
    Probl Tuberk; 1989; (4):39-42. PubMed ID: 2734263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis: relevance of isoniazid dosage in prevention of liver side effects].
    Negri L; Le Grusse J; Séraissol P; Lavit M; Houin G; Gandia P
    Therapie; 2014; 69(6):509-16. PubMed ID: 25314930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoprotective effect of isonicotinoylhydrazone SH7 against chronic isoniazid toxicity.
    Georgieva N; Gadjeva V; Tolekova A; Dimitrov D
    Pharmazie; 2005 Feb; 60(2):138-41. PubMed ID: 15739904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
    Skakun NP; Tabachuk OE
    Probl Tuberk; 1991; (10):77-9. PubMed ID: 1788241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: The isoniazid problem.
    Farer LS
    Gastroenterology; 1976 Apr; 70(4):631. PubMed ID: 1254145
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor.
    Sarich TC; Adams SP; Petricca G; Wright JM
    J Pharmacol Exp Ther; 1999 May; 289(2):695-702. PubMed ID: 10215642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.